Robert N. is a highly accomplished business executive and consultant, with a wealth of experience in the pharmaceutical and biotechnology industries. With a Doctor of Philosophy in Chemistry from the University of Glasgow and additional studies at Harvard University and the London Business School, Robert has a rare combination of scientific knowledge and management expertise.

Robert has held a variety of senior positions at top companies, including Eli Lilly and Roche. At Roche, he was Director of Business Development and Licensing, Alliance Director, and Project Team Leader. He later served as Director of the Asia Pacific region for Eli Lilly and was also Chief Business Officer of Pharnext. He also founded and served as Managing Director of Ec Pharma Consulting and Biobasel Consulting Gmbh.

Robert has a deep understanding of drug development, marketing, and financing, as well as a talent for identifying promising research and development opportunities. He has been an advisor to Inkef Capital and Managing Director, Head of Financial Advisory Business at Chinabio Capital Partners.

Overall, Robert is a respected leader in the pharmaceutical and biotech industries and brings a combination of scientific and business expertise to his work.